Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Jayson

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Anticancer Research|September 15, 2005
Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculatureS D Shnyder, J Hasan, P A Cooper, et al.
British Journal of Cancer|January 23, 2014
Thrombosis in ovarian cancer: a case control studyR L Metcalf, D J Fry, R Swindell, et al.
British Journal of Cancer|October 2, 2003
A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinomaA R Clamp, F H Blackhall, P Vasey, et al.
ESMO Open|November 16, 2016
Does clinical trial participation improve outcomes in patients with ovarian cancer?L Khoja, L Horsley, A Heesters, et al.
British Journal of Cancer|April 18, 2007
Heparan sulphate synthetic and editing enzymes in ovarian cancerA C Backen, C L Cole, S C Lau, et al.
British Journal of Cancer|July 31, 2003
Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancyS E Duff, C Li, M Jeziorska, et al.
British Journal of Haematology|September 6, 2000
Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescueA M Wardley, G C Jayson, R Swindell, et al.
The British Journal of Radiology|April 10, 2003
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting gliomaA Jackson, G C Jayson, K L Li, et al.
British Journal of Cancer|August 1, 1995
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusionG C Jayson, D Crowther, J Prendiville, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 1, 2010
Cross-visit tumor sub-segmentation and registration with outlier rejection for dynamic contrast-enhanced MRI time series dataG A Buonaccorsi, C J Rose, J P B O'Connor, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Anticancer Research|September 15, 2005
Development of a modified hollow fibre assay for studying agents targeting the tumour neovasculatureS D Shnyder, J Hasan, P A Cooper, et al.
British Journal of Cancer|January 23, 2014
Thrombosis in ovarian cancer: a case control studyR L Metcalf, D J Fry, R Swindell, et al.
British Journal of Cancer|October 2, 2003
A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinomaA R Clamp, F H Blackhall, P Vasey, et al.
ESMO Open|November 16, 2016
Does clinical trial participation improve outcomes in patients with ovarian cancer?L Khoja, L Horsley, A Heesters, et al.
British Journal of Cancer|April 18, 2007
Heparan sulphate synthetic and editing enzymes in ovarian cancerA C Backen, C L Cole, S C Lau, et al.
British Journal of Cancer|July 31, 2003
Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancyS E Duff, C Li, M Jeziorska, et al.
British Journal of Haematology|September 6, 2000
Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescueA M Wardley, G C Jayson, R Swindell, et al.
The British Journal of Radiology|April 10, 2003
Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting gliomaA Jackson, G C Jayson, K L Li, et al.
British Journal of Cancer|August 1, 1995
A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusionG C Jayson, D Crowther, J Prendiville, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 1, 2010
Cross-visit tumor sub-segmentation and registration with outlier rejection for dynamic contrast-enhanced MRI time series dataG A Buonaccorsi, C J Rose, J P B O'Connor, et al.
Pageof 7